baseline progression

基本解釋

Atherosclerosis progression was assessed at baseline and at 24 months of treatment.
在基線和治療24小時后測量了動脈粥樣硬化的進展。
During follow-up, 12% of men with prevalent spondylolisthesis had progression; 12% without baseline spondylolisthesis had new onset.
隨訪時，12%的病例病情進展，12%原來未合并脊椎前移的病人罹患此癥。
All patients had Response Evaluation Criteria in Solid Tumors-defined disease progression documented within 12 months before baseline.
所有患者均有RECIST標(biāo)準(zhǔn)所確定的基線前12個月中有記錄的疾病進展。